NOX5 and atherosclerosis: Based on the fact that oxidative stress is instrumental in atherogenesis, pharmacological targeting of epigenetic-based pathways that control Nox5 expression might be a noteworthy novel therapeutic strategy in atherosclerosis rather than direct scavenging ROS.